SCIORTINO, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 1.905
AS - Asia 838
SA - Sud America 530
EU - Europa 342
Continente sconosciuto - Info sul continente non disponibili 54
AF - Africa 43
Totale 3.712
Nazione #
US - Stati Uniti d'America 1.838
BR - Brasile 467
SG - Singapore 359
CN - Cina 162
IT - Italia 89
HK - Hong Kong 80
VN - Vietnam 78
FI - Finlandia 57
UA - Ucraina 42
DE - Germania 37
FR - Francia 32
AR - Argentina 27
CA - Canada 25
IN - India 23
MX - Messico 23
TR - Turchia 23
GB - Regno Unito 21
IQ - Iraq 20
BD - Bangladesh 17
ZA - Sudafrica 17
PL - Polonia 14
EC - Ecuador 11
JP - Giappone 11
KR - Corea 11
SE - Svezia 11
NL - Olanda 10
ID - Indonesia 9
JO - Giordania 8
VE - Venezuela 8
ES - Italia 7
MA - Marocco 7
RU - Federazione Russa 7
UZ - Uzbekistan 7
CO - Colombia 6
PK - Pakistan 5
HN - Honduras 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
BE - Belgio 3
CL - Cile 3
GT - Guatemala 3
KE - Kenya 3
NP - Nepal 3
PH - Filippine 3
PY - Paraguay 3
AO - Angola 2
AZ - Azerbaigian 2
CG - Congo 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
IE - Irlanda 2
JM - Giamaica 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PE - Perù 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
TN - Tunisia 2
UY - Uruguay 2
AL - Albania 1
DZ - Algeria 1
EG - Egitto 1
GA - Gabon 1
GE - Georgia 1
GF - Guiana Francese 1
GP - Guadalupe 1
HU - Ungheria 1
IL - Israele 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
MN - Mongolia 1
NA - Namibia 1
OM - Oman 1
QA - Qatar 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TZ - Tanzania 1
YT - Mayotte 1
Totale 3.658
Città #
Dallas 458
San Jose 227
Chandler 209
Singapore 183
Ashburn 123
Council Bluffs 109
Hong Kong 79
Santa Clara 78
Beijing 63
Columbus 47
Princeton 38
Helsinki 34
São Paulo 30
Lauterbourg 28
Milan 28
Ho Chi Minh City 26
Shanghai 23
Hanoi 21
Los Angeles 20
New York 18
Mountain View 15
Orem 15
Wilmington 14
Falkenstein 13
Rio de Janeiro 13
The Dalles 13
Warsaw 12
Phoenix 11
Belo Horizonte 10
Brasília 9
Espoo 9
Seoul 9
Tokyo 9
Amman 8
Denver 8
Frankfurt am Main 8
Johannesburg 8
Toronto 8
Atlanta 7
Lappeenranta 7
Querétaro 7
Salvador 7
San Francisco 7
Baghdad 6
Coventry 6
Jakarta 6
Mexico City 6
Montreal 6
Porto Alegre 6
Tashkent 6
Turku 6
Boardman 5
Boston 5
Campinas 5
Cape Town 5
Chennai 5
Chicago 5
Curitiba 5
Genoa 5
Osasco 5
Quartucciu 5
Recife 5
Rome 5
Santo André 5
Stockholm 5
Amsterdam 4
Ankara 4
Diadema 4
Florianópolis 4
Guarulhos 4
Guayaquil 4
Haiphong 4
Istanbul 4
Maringá 4
Munich 4
Nuremberg 4
Poplar 4
Sorocaba 4
Sumaré 4
Washington 4
Ann Arbor 3
Barbianello 3
Brooklyn 3
Brussels 3
Buffalo 3
Bắc Ninh 3
Campo Grande 3
Caracas 3
Cleveland 3
Da Nang 3
Erbil 3
Franca 3
Guatemala City 3
Houston 3
Jacksonville 3
Kilis 3
Las Vegas 3
London 3
Manaus 3
Manchester 3
Totale 2.307
Nome #
Chemistry of mixed-ligand oxidovanadium(IV) complexes of aroylhydrazones incorporating quinoline derivatives: Study of solution behavior, theoretical evaluation and protein/DNA interaction 153
Covalent and non-covalent binding in vanadium–protein adducts 151
Binding of potential antitumor Casiopeínas® to small proteins 145
DFT Protocol for EPR Prediction of Paramagnetic Cu(II) Complexes and Application to Protein Binding Sites 142
Biospeciation of Potential Vanadium Drugs of Acetylacetonate in the Presence of Proteins 140
ESI-MS Study of the Interaction of Potential Oxidovanadium(IV) Drugs and Amavadin with Model Proteins 138
Binding of VIV O2+ , VIV OL, VIV OL2 and VV O2 L Moieties to Proteins: X-ray/Theoretical Characterization and Biological Implications 131
Effect of secondary interactions, steric hindrance and electric charge on the interaction of VIVO species with proteins 129
Rationalizing the Decavanadate(V) and Oxidovanadium(IV) Binding to G-Actin and the Competition with Decaniobate(V) and ATP 128
A Series of Non-Oxido VIVComplexes of Dibasic ONS Donor Ligands: Solution Stability, Chemical Transformations, Protein Interactions, and Antiproliferative Activity 127
Unveiling VIVO2+ Binding Modes to Human Serum Albumins by an Integrated Spectroscopic–Computational Approach 120
Binding of vanadium ions and complexes to proteins and enzymes in aqueous solution 119
Protein‐Protein Stabilization in VIVO/8‐Hydroxyquinoline–Lysozyme Adducts 118
Mo(VI) Potential Metallodrugs: Explaining the Transport and Cytotoxicity by Chemical Transformations 118
Through-Space Spin Coupling in a Silver(II) Porphyrin Dimer upon Stepwise Oxidations: AgII⋅⋅⋅AgII, AgII⋅⋅⋅AgIII, and AgIII⋅⋅⋅AgIII Metallophilic Interactions 116
Quantitative prediction of electronic absorption spectra of copper(II)–bioligand systems: Validation and applications 115
Solution chemistry of oxidovanadium(IV) complexes with two bis-kojic acid derivatives 114
New VIV, VIVO, VVO, and VVO2Systems: Exploring their Interconversion in Solution, Protein Interactions, and Cytotoxicity 113
Polyoxovanadates with emerging biomedical activities 112
Integrated experimental/computational approaches to characterize the systems formed by vanadium with proteins and enzymes 99
Ferromagnetic Coupling in Oxidovanadium(IV)-Porphyrin Radical Dimers 99
Solution chemical properties and anticancer potential of 8-hydroxyquinoline hydrazones and their oxidovanadium(IV) complexes 97
Experimental and Computational Studies on the Interaction of DNA with Hesperetin Schiff Base CuII Complexes 97
Stepwise Oxidations in a Cofacial Copper(II) Porphyrin Dimer: Through-Space Spin-Coupling and Interplay between Metal and Radical Spins 96
Interaction of VIVO–8-hydroxyquinoline species with RNase A: the effect of metal ligands in the protein adduct stabilization 95
New mixed ligand oxidovanadium(IV) complexes: Solution behavior, protein interaction and cytotoxicity 94
Implications of Protein Interaction in the Speciation of Potential VIVO-Pyridinone Drugs 94
Interaction with CT-DNA and in vitro cytotoxicity of two new copper(II)-based potential drugs derived from octanoic hydrazide ligands 92
Promising anticancer agents based on 8-hydroxyquinoline hydrazone copper(II) complexes 92
Multiple and Variable Binding of Pharmacologically Active Bis(maltolato)oxidovanadium(IV) to Lysozyme 92
Polyoxidovanadates' interactions with proteins: An overview 83
The binding modes of VIVO2+ions in blood proteins and enzymes 79
Stabilization and Binding of [V4O12]4− and Unprecedented [V20O54(NO3)]n− to Lysozyme upon Loss of Ligands and Oxidation of the Potential Drug VIVO(acetylacetonato)2 74
Totale 3.712
Categoria #
all - tutte 15.492
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.492


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202293 0 0 0 0 9 1 2 9 10 8 7 47
2022/2023332 32 42 16 57 20 48 0 42 64 1 8 2
2023/202491 18 7 4 8 20 4 0 3 4 0 10 13
2024/20251.027 4 8 45 25 23 57 102 201 316 154 66 26
2025/20261.618 57 298 287 217 162 101 254 50 65 70 48 9
2026/2027479 38 109 150 182 0 0 0 0 0 0 0 0
Totale 3.712